FDA Grants Torisel NDA Priority Review Status (Medical News Today)
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) has accepted the file and granted priority review status to the Company's New Drug Application (NDA) for the investigational drug Torisel(TM) (temsirolimus). [click link for full article]

CoSign Electronic Signatures Ensure AstroMed Meets FDA's 21 CFR Part 11 Compliancy (Business Wire via Yahoo! Finance)
PLEASANT HILL, Calif.----Algorithmic Research , a leading worldwide provider of electronic signatures and data security solutions has implemented a CoSign Electronic Signature appliance at AstroMed, Inc. , to enable compliance with the FDA regulations.